In January-September 2025, pharmaceutical manufacturer Monfarm (Cherkasy region) increased its net profit by 9.6 times compared to the same period in 2024, to UAH 25.176 million.
According to the company’s disclosure to the National Securities and Stock Market Commission, its net sales revenue for this period increased by 34.7% to UAH 233.655 million.
Monfarm PJSC was established in 1994 through the corporatization and privatization of the Monastyryshchensky Pharmaceutical Plant, a state-owned enterprise organized in 1986 on the basis of an alcohol plant as part of the Kyiv pharmaceutical association Darnitsa.
Monfarm specializes in the production of suppositories and tableted medicines, with more than 70 names of medicines from various pharmaceutical groups.
The quality of the products is confirmed by GMP certificates.
